Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-001484

Director sold 20,054 shares at an average $13.62 ($273,202)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Borgeson Blake · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-09 Sale : show line 1 in the form 10b5-1 −6,303 $13.21 $83,278 7,358,169 D
2024-01-09 Sale : show line 2 in the form 10b5-1 −13,751 $13.81 $189,925 7,344,418 D
Open-market sales · 20,054 sh · avg $13.62 · $273,202
Loading xslF345X05/doc4.xml…